A multicenter phase 2 single arm study of #cabozantinib in patients with advanced or unresectable #renalcell carcinoma pre-treated with one immune-checkpoint inhibitor 👉The #BREAKPOINT trial (Meet-Uro trial 03) @meeturoIT Read the article here 🔗https://
460 followers
364 followers
RT @TumoriJ: @IstTumori Dr Mélanie Claps and Dr Giuseppe Procopio discuss about the results of the Breakpoint Trial evaluating efficacy and…
170 followers
RT @TumoriJ: @IstTumori Dr Mélanie Claps and Dr Giuseppe Procopio discuss about the results of the Breakpoint Trial evaluating efficacy and…
5,213 followers
RT @TumoriJ: @IstTumori Dr Mélanie Claps and Dr Giuseppe Procopio discuss about the results of the Breakpoint Trial evaluating efficacy and…